Last reviewed · How we verify

NCT07423806

Evaluation of Modified Le Fort I Osteotomy for Treating Cleft Lip and Palate Patients

Completed Phase 4 Last updated 20 February 2026
What this trial tests

Phase 4 trial testing segmental Le Fort I (SLF-1) osteotomy in Cleft Lip Palate in 9 participants. Completed in 30 June 2023.

Timeline
1 January 2020
Primary endpoint
1 January 2023
30 June 2023

Quick facts

Lead sponsorAlexandria University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment9
Start date1 January 2020
Primary completion1 January 2023
Estimated completion30 June 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

15 and older, any sex, with Cleft Lip Palate or Class III Skeletal Malocclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nine adults with Angle class III relation and persistent alveolar bone defect due to CL/P deformity were included. SLF-1 maxillary advancement was performed. Lateral profile analysis and alveolar bone defect volume were assessed before and after the surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cleft Lip Palate

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07423806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing